Thalamic pleomorphic xanthoastrocytoma central nervous system World Health Organization grade 3
Pleomorphic xanthoastrocytoma (PXA) is a rare astrocytic tumor. According to the 2021 World Health Organization (WHO) classification of central nervous system (CNS) tumors, PXAs with 5 or more mitoses per 10 high-power fields are classified as CNS WHO grade 3. Imaging findings of PXA CNS WHO grade 3 have rarely been reported, and thalamic cases are particularly uncommon. We present a case of thalamic PXA CNS WHO grade 3. A 71-year-old male presented with progressive right hemiparesis over three months. Magnetic resonance imaging (MRI) revealed a mass lesion in the left thalamus. Due to rapid tumor growth causing obstructive hydrocephalus, he underwent urgent craniotomy for tumor resection. Histopathology confirmed a PXA CNS WHO grade 3. Postoperatively, the patient received 54 Gy of radiation therapy in 27 fractions. His right hemiparesis persisted. He was subsequently transferred to a rehabilitation hospital.
Authors
- Hirofumi Sakamoto
- Kosuke Nakajo (ORCID: https://orcid.org/0000-0001-9481-0167)
- Junko Hirato (ORCID: https://orcid.org/0000-0002-8278-6240)
- Taro Shimono (ORCID: https://orcid.org/0000-0001-5847-6587)
- Yukio Miki (ORCID: https://orcid.org/0000-0003-0621-0044)
- Shigeru Hiramatsu
- Hayato Ikota
- Maciej Pas (ORCID: https://orcid.org/0000-0002-5466-6524)
- Hirotaka Takita (ORCID: https://orcid.org/0000-0003-2860-4503)
- Tsutomu Ichinose (ORCID: https://orcid.org/0000-0002-8576-5074)
- Sayaka Tanaka
Institutions
- Osaka City University (JP)
- Gunma Museum of Natural History (JP)
- Gunma University Hospital (JP)
- Osaka City University Hospital (JP)
- Osaka Metropolitan University (JP)
Publication Details
- Journal
- Radiology Case Reports
- Published
- 2025-05-06
- DOI
- https://doi.org/10.1016/j.radcr.2025.04.036
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00